Sea Moss for Inflammatory Bowel Disease: Gut Lining, Anti-Inflammatory & Microbiome Support

Inflammatory bowel disease (IBD) -- encompassing Crohn's disease and ulcerative colitis -- affects 3.1 million Americans with chronic intestinal inflammation, mucosal damage, and dysbiosis. IBD is driven by dysregulated Th1/Th17 immune responses, epithelial barrier dysfunction, and microbial translocation. Sea moss fucoidan modulates intestinal NF-kB and IL-6/TNF-alpha; sea moss prebiotic fiber (FOS, carrageenan) supports Lactobacillus/Bifidobacteria restoration; zinc and selenium support intestinal epithelial tight junction repair; mucilaginous polysaccharides may provide mucosal coating. Biologics (vedolizumab, ustekinumab, infliximab) and aminosalicylates are standard -- sea moss provides gut-targeted anti-inflammatory nutritional support alongside gastroenterologist care.

Read the full guide